University Compounding Pharmacy Rebrands as MediVera Compounding Pharmacy™ Amidst Significant Growth
TL;DR
The rebranding of University Compounding Pharmacy as MediVera Compounding Pharmacy™ provides a strong advantage through nationwide expansion and new product offerings.
MediVera Compounding Pharmacy™ has been dedicated to providing personalized medicine since 1999 and is licensed in and ships to 33 states.
The company's commitment to tailored solutions for healthcare providers and patients is making the world a better place by setting industry standards and offering exceptional care.
MediVera Compounding Pharmacy™ is poised for strong growth in 2024 with expansion plans into 14 additional states and the Impressed Advantage program making the prescription process easier and faster.
Found this article helpful?
Share it with your network and spread the knowledge!
University Compounding Pharmacy, a leader in personalized medicine since 1999, has announced it is rebranding as MediVera Compounding Pharmacy™. This change coincides with the company's robust growth driven by new product introductions, nationwide expansion, and a successful differentiation strategy for its quality products and services.
Despite the new name, the company's ownership and dedicated team remain unchanged, ensuring the continuity of the high-level service and exceptional care that healthcare providers and patients have trusted for over two decades.
In recent years, the company has experienced substantial revenue growth. Enhanced product offerings, nationwide expansion, and a strong market position through differentiated quality products and services, such as the Impressed Advantage program, have enabled the company to double its revenue from 2022 to 2023. The growth momentum is expected to continue, with projections to double revenue year-over-year once again.
“Differentiation is and will continue to be an important growth driver for our company. With the Impressed Advantage customer service program, we are making the prescription process easier, faster, and more convenient for both doctors and their patients,” said Bradley McCloskey, PharmD, CEO. “As we continue to launch more product offerings and expand into more states within the next few months, 2024 is poised to become a year of strong growth as we expand our footprint into 14 additional states.”
MediVera Compounding Pharmacy is currently licensed in and ships to the following 33 states: AZ, CN, CO, DE, FL, GA, IA, ID, IL, IN, KY, MA, MD, ME, MI, MN, MO, MT, NC, NH, NJ, NY, OH, PA, RI, SC, SD, TN, VA, VT, WA, WI, WY.
For more details about MediVera Compounding Pharmacy and its services, please visit mediverarx.com.
Curated from News Direct
